Fixed-Ratio Combination Treatment with Basal Insulin and GLP-1 Receptor Agonists

“New Developments in Type 2 Diabetes Management” is a new series dedicated to providing healthcare professionals with the latest education on novel fixed-ratio combination treatment options for patients with type 2 diabetes. Experts will cover the benefits of fixed-ratio combinations of basal insulin analogs and GLP-1 receptor agonists, individualized treatment plans, and current barriers to patient care. In addition, the faculty will demonstrate the proper administration of these new combination agents. Gain valuable insights to help your diabetic patients achieve optimal results all while receiving free CME/CNE credit. 

Episodes 0-0 of 0


    We’re glad to see you’re enjoying Eye Health Academy…
    but how about a more personalized experience?

    Register for free